DavidM.BaerMD

Oncology • Richmond, CA

Hematologic Oncology

Hematology Oncology Kaiser Permanente Oakland

Join to view full profile

Dr. Baer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Baer's full profile

Already have an account?

Office
901 Nevin Ave
Richmond, CA 94801
Phone+1 510-307-2325
Is this information wrong?

Education & Training

University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1981
Kaiser Permanente Northern California (San Francisco)Residency, Internal Medicine, 1975 - 1978
Kaiser Permanente San Francisco Medical Center1975 - 1976
University of California San Francisco School of MedicineClass of 1975

Certifications & Licensure

CA State Medical License 1976 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Oakland Magazine Castle Connolly, 2006
Fellow (FACP) American College of Physicians, 1997
Super Doctor SuperDoctors.com
Join now to see all

Publications & Presentations

PubMed

3 citations
Characteristics of Ocular Inflammatory Side Effects Associated with Immune Checkpoint Inhibitors in a Northern California Population.
Ying Qian, Sarah Eppley, David Baer, Ronald B Melles> ;Ocular Immunology and Inflammation. 2024 Jan 1
1 citations
A prognostic information system for real-time personalized care: Lessons for embedded researchers.
Tracy A. Lieu, Lisa J. Herrinton, Tami Needham, Michael Ford, Liyan Liu, Deborah Lyons, Joseph Macapinlac, Romain Neugebauer, Daniel Ng, Stephanie Prausnitz, Wendi Rob...> ;Healthcare. 2021 Jun 1
Regionalization of Acute Myeloid Leukemia Treatment in a Community-Based Population: Implementation and Early Results.
Lisa Y Law, Stephen Uong, Hyma T. Vempaty, Vu H Nguyen, David Baer, Vincent X. Liu, Lisa J. Herrinton> ;The Permanente Journal. 2021 May 1
11 citations
Low-dose versus High-dose Carfilzomib with Dexamethasone (S1304) in Patients with Relapsed-Refractory Multiple Myeloma
Sikander Ailawadhi, Rachael Sexton, Suzanne Lentzsch, Muneer H. Abidi, Peter M. Voorhees, Adam D. Cohen, Eric M. Rohren, Stephen B. Heitner, Kevin R. Kelly, Niklas J. ...> ;Clinical Cancer Research. 2020 Aug 1
5 citations
Amyloid cardiomyopathy in a large integrated health care system.
Peter Czobor, Yun-Yi Hung, David M. Baer, Dana McGlothlin, Dana Weisshaar, Jonathan G. Zaroff> ;American Heart Journal. 2019 Oct 1
3 citations
Developing a Prognostic Information System for Personalized Care in Real Time.
Tracy A. Lieu, Lisa J. Herrinton, Dimitri E. Buzkov, Liyan Liu, Deborah Lyons, Romain Neugebauer, Tami Needham, Daniel Ng, Stephanie Prausnitz, Kam Stewart, Stephen K....> ;EGEMS. 2019 Mar 25
Good Cooking Stories … for Now.
David Baer> ;The Permanente Journal. 2019 Jan 1
40 citations
Incidence of Hepatitis B Virus Reactivation and Hepatotoxicity in Patients Receiving Long-term Treatment With Tumor Necrosis Factor Antagonists
Mary Patricia Pauly, Lue Yen Tucker, Jean Luc Szpakowski, Joanna Ready, David Baer, Jessica P. Hwang, Anna S.F. Lok> ;Clinical Gastroenterology and Hepatology. 2018 Dec 1
Drug Combinations with Transplantation for Myeloma
Baer, D.> ;The New England journal of medicine. 2017 Jul 12
13 citations
Alcohol Intake, Beverage Choice, and Cancer: A Cohort Study in a Large Kaiser Permanente Population
Arthur L. Klatsky, Yan Li, H. Nicole Tran, David Baer, Natalia Udaltsova, Mary Anne Armstrong, Gary D. Friedman> ;The Permanente Journal. 2015 Mar 1
21 citations
Moderate alcohol intake and cancer: the role of underreporting
Arthur L. Klatsky, Natalia Udaltsova, Yan Li, David Baer, H. Nicole Tran, Gary D. Friedman> ;Cancer Causes & Control. 2014 Apr 2
20 citations
Efficacy of abbreviated Stanford V chemotherapy and involved-field radiotherapy in early-stage Hodgkin lymphoma: mature results of the G4 trial
Ranjana H. Advani, Richard T. Hoppe, David Baer, Roger A. Warnke, Jeff Allen, Sarah E. Daadi, Saul A. Rosenberg, Sandra J. Horning> ;Annals of Oncology. 2013 Apr 1
11 citations
Predictors of Lung Cancer: Noteworthy Cell Type Differences
H.N. Tran, Yan Li, Stanton Siu, David Baer, Gary D. Friedman, Natalia Udaltsova, Arthur L. Klatsky> ;The Permanente Journal. 2013 Jan 1
59 citations
Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy.
Stephanie T. Chang, Adam S. Tenforde, Christopher D. Grimsrud, Felice O'Ryan, Joel R. Gonzalez, David M. Baer, Malini Chandra, Joan C. Lo> ;Bone. 2012 Sep 1
9 citations
Stage I-IIA non-bulky Hodgkin's lymphoma. Is further distinction based on prognostic factors useful? The Stanford experience.
Ranjana H. Advani, Richard T. Hoppe, Lauren S. Maeda, David Baer, Saul A. Rosenberg, Sandra J. Horning> ;International Journal of Radiation Oncology, Biology, Physics. 2011 Dec 1
43 citations
Patient-Physician E-Mail Communication: The Kaiser Permanente Experience
David Baer> ;Journal of Oncology Practice. 2011 Jul 1
13 citations
Alcohol Consumption and Risk of Hematologic Malignancies
Arthur L. Klatsky, Yan Li, David Baer, Mary Anne Armstrong, Natalia Udaltsova, Gary D. Friedman> ;Annals of Epidemiology. 2009 Oct 1
130 citations
Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
Felice O'Ryan, Sam Khoury, Wendy P. Liao, Myo M. Han, Rita L. Hui, David Baer, Daniel Martin, Donald Liberty, Joan C. Lo> ;Journal of Oral and Maxillofacial Surgery. 2009 Jul 1
Phase II trial of nab-paclitaxel as first-line therapy of hormone refractory metastatic prostate cancer (HRPC).
Kolevska T, Ryan CJ, Huey V, Weisberg L, Wang S, Baer D, Ghadialy A, Goldstein D, Fireman B, Fehrenbacher L> ;J. Clin. Oncol.. 2009-05-20
31 citations
Wine, liquor, beer and risk of breast cancer in a large population.
Yan Li, David Baer, Gary D. Friedman, Natalia Udaltsova, Veronica Shim, Arthur L. Klatsky> ;European Journal of Cancer. 2009 Mar 1
143 citations
Medication Errors Among Adults and Children With Cancer in the Outpatient Setting
Kathleen E. Walsh, Katherine S. Dodd, Kala Seetharaman, Douglas W. Roblin, Lisa J. Herrinton, Ann Von Worley, G. Naheed Usmani, David Baer, Jerry H. Gurwitz> ;Journal of Clinical Oncology. 2009 Feb 20
7 citations
Does the association between serum endostatin, an endogenous anti-angiogenic protein, and acute myocardial infarction differ by race?
Carlos Iribarren, Lisa J. Herrinton, Jeanne Darbinian, Lawrence Tamarkin, Donald Malinowski, Joseph H. Vogelman, Norman Orentreich, David M. Baer> ;Vascular Medicine. 2006 Feb 1
20 citations
What protects Asians from venous thromboembolism
Arthur L. Klatsky, David Baer> ;The American Journal of Medicine. 2004 Apr 1
57 citations
Stanford-Kaiser Permanente G1 study for clinical stage I to IIA Hodgkin's disease: subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemot...
Sandra J. Horning, Richard T. Hoppe, Byron W. Brown, Steven L. Hancock, David Baer, Saul A. Rosenberg> ;Journal of Clinical Oncology. 1997 May 1
11 citations
Hereditary iron overload and African Americans
David Baer> ;The American Journal of Medicine. 1996 Jul 1
Join now to see all

Abstracts/Posters

Change in Treatments and Complications after Regionalizing High-Intensity Induction of Acute Myeloid Leukemia in a Community-Based Population, 2013-2017
David M. Baer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
American College of Physicians - ACP
Fellow

Hospital Affiliations

Kaiser Permanente Oakland Medical CenterOakland, California